CCLD Stock Analysis: Buy, Sell, or Hold?
CCLD - CareCloud, Inc. Common Stock
$2.22
-0.05 (-2.20%)
▼
5d:
+6.73%
30d:
-9.76%
90d:
-38.67%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 04, 2026
30d
Get Alerted When CCLD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CCLD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CCLD appears deeply undervalued. Market expects -13.2% annual earnings decline despite 5739% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: CCLD appears deeply undervalued. Market expects -13.2% annual earnings decline despite 5739% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.19
Based on -8.0% avg growth
INTRINSIC VALUE TODAY
$1.36
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCLD is currently trading at $2.22, which is considered fair relative to its 30-day fair value range of $2.16 to $2.37. From a valuation perspective, the stock is trading at a discount (Forward PE: 7.6) compared to its historical average (11.6). Remarkably, the market is currently pricing in an annual earnings decline of 13.2% over the next few years. This pessimistic expectation contrasts with the company's recent 5739.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.07, while resistance sits at $2.33.
Market Sentiment: CCLD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+175.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCLD is in a uptrend. Immediate support is located at $2.07, while resistance sits at $2.33.
Market Sentiment: CCLD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.12 (+175.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.16 -
$2.37
Company Quality Score
65/100
(BUY)
Options IV Signal
37th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 37th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 175.9% below Wall St target ($6.12)
Trading Range Analysis
30-Day Trading Range
$2.16 -
$2.37
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.29
(12.9%)
Support & Resistance Levels
Support Level
$2.07
Resistance Level
$2.34
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
7.57
Wall Street Target
$6.13
(+175.9%)
Revenue Growth (YoY)
13.2%
Earnings Growth (YoY)
5739.0%
Profit Margin
7.9%
Valuation Discount vs History
-13.2% cheaper
PE vs Historical
7.6 vs 11.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.2%
(market-implied from PE analysis)
1-Year Target
$2.00
(-10%)
2-Year Target
$1.80
(-19%)
3-Year Target
$1.62
(-27%)
3-Yr Target (if PE normalizes)
(PE: 8→12)
$2.48
(+12%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -20.0%)
$4.66
(+110%)
Base:
(SPY PE: 7.6, Growth: -20.0%)
$1.62
(-27%)
Bear:
(PE: 6.4, Growth: -20.0%)
$1.38
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 17.46 | Current EPS (TTM): $0.13
Bull Case
$4.99
(+125%)
Analyst growth 100.0%, PE expands to 19.2
Base Case
$4.54
(+105%)
Market implied 100.0%, PE stable at 17.5
Bear Case
$1.54
(-31%)
Severe decline -20.0%, PE contracts to 14.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 7.6 to 11.6
Stabilization Target:
$3.40
(+53.3%)
PE Expansion Potential:
+53.3%
Share & Embed Analysis
Last updated: July 03, 2026 10:58 PM ET
Data refreshes hourly during market hours. Next update: 11:58 PM
Data refreshes hourly during market hours. Next update: 11:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCLD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
